Paper · 42979107
paRDal: bioinformatics framework for a parallel RNA and DNA NGS analysis in hereditary cancer diagnostics.
Matejkova K and 12 others. Front Bioinform, 2026.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. paRDal: bioinformatics framework for a parallel RNA and DNA NGS analysis in hereditary cancer diagnostics. Papers, record 42979107. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42979107
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- paRDal: bioinformatics framework for a parallel RNA and DNA NGS analysis in hereditary cancer diagnostics.
- Journal
- Front Bioinform
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-11-05
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References62
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 40,585,303 | MOLGENIS VIP: an end-to-end DNA variant interpretation pipeline for research and diagnostics configurable to support rapid implementation of new methods. | NAR Genom Bioinform | 2025 | https://conductscience.org/library/papers/40585303 | PubMed |
| 2 | 28,279,309 | Allele-specific wild-type TP53 expression in the unaffected carrier parent of children with Li-Fraumeni syndrome. | Cancer Genet | 2017 | https://conductscience.org/library/papers/28279309 | PubMed |
| 3 | 36,529,447 | Germline-focused analysis of tumour-detected variants in 49,264 cancer patients: ESMO Precision Medicine Working Group recommendations. | Ann Oncol | 2023 | https://conductscience.org/library/papers/36529447 | PubMed |
| 4 | 25,431,634 | From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. | Curr Protoc Bioinformatics | 2013 | https://conductscience.org/library/papers/25431634 | PubMed |
| 5 | 39,902,189 | Refining the interpretation of variants of uncertain significance in hereditary cancer screening through integrated RNA sequencing. | Genet Med Open | 2025 | https://conductscience.org/library/papers/39902189 | PubMed |
| 6 | 32,127,026 | Variants of uncertain significance in the era of high-throughput genome sequencing: a lesson from breast and ovary cancers. | J Exp Clin Cancer Res | 2020 | https://conductscience.org/library/papers/32127026 | PubMed |
| 7 | 31,679,514 | MaveDB: an open-source platform to distribute and interpret data from multiplexed assays of variant effect. | Genome Biol | 2019 | https://conductscience.org/library/papers/31679514 | PubMed |
| 8 | 40,627,838 | Semi-automated RNA Isolation from Tempus Blood RNA Tubes Using the Magcore Plus II Instrument. | Folia Biol (Praha) | 2025 | https://conductscience.org/library/papers/40627838 | PubMed |
| 9 | 40,436,861 | Cracking rare disorders: a new minimally invasive RNA-seq protocol. | NPJ Genom Med | 2025 | https://conductscience.org/library/papers/40436861 | PubMed |
| 10 | 34,758,253 | 100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report. | N Engl J Med | 2021 | https://conductscience.org/library/papers/34758253 | PubMed |
1 to 10 of 62
See all 62 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first.
None in this release.
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42979107
GET https://conductscience.org/api/papers/v1/42979107/references?page=2